{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:24:30Z","timestamp":1740144270114,"version":"3.37.3"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS36126, P01 DA028555, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261 and R01 AG043540","R01 AG043540, R24 OD 018546-01","R24 OD 018546-01","R01 MH079717"],"award-info":[{"award-number":["R01 NS36126, P01 DA028555, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261 and R01 AG043540","R01 AG043540, R24 OD 018546-01","R24 OD 018546-01","R01 MH079717"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11481-016-9686-5","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T03:30:27Z","timestamp":1467171027000},"page":"484-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuropharmacologic Approaches to Restore the Brain\u2019s Microenvironment"],"prefix":"10.1007","volume":"11","author":[{"given":"Weizhe","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-I","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa Y","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML (2013) Microglia: scapegoat, saboteur, or something else? Science 339:156\u2013161","journal-title":"Science"},{"key":"9686_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12020-008-9136-0","volume":"35","author":"RAM Ahmed","year":"2009","unstructured":"Ahmed RAM, Murao K, Imachi H, Yoshida K, Dobashi H, Hosomi N, Ishida T (2009) c-Jun N-terminal kinases inhibitor suppresses the TNF-\u03b1 induced MCP-1 expression in human umbilical vein endothelial cells. Endocrine 35:184\u2013188","journal-title":"Endocrine"},{"key":"9686_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/157016208785861195","volume":"6","author":"A Alexaki","year":"2008","unstructured":"Alexaki A, Liu Y, Wigdahl B (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 6:388","journal-title":"Curr HIV Res"},{"key":"9686_CR4","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1523\/JNEUROSCI.1933-04.2004","volume":"24","author":"ER Anderson","year":"2004","unstructured":"Anderson ER, Gendelman HE, Xiong H (2004) Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis the. J Neurosci 24:7194\u20137198","journal-title":"J Neurosci"},{"key":"9686_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","volume":"39","author":"BL Apostol","year":"2008","unstructured":"Apostol BL et al. (2008) CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice. Mol Cell Neurosci 39:8\u201320","journal-title":"Mol Cell Neurosci"},{"key":"9686_CR6","doi-asserted-by":"publisher","first-page":"N65","DOI":"10.1088\/0031-9155\/57\/7\/N65","volume":"57","author":"B Baseri","year":"2012","unstructured":"Baseri B et al. (2012) Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood\u2013brain barrier using focused ultrasound and microbubbles. Phys Med Biol 57:N65","journal-title":"Phys Med Biol"},{"key":"9686_CR7","unstructured":"Benarroch EE (2005) Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. In: Mayo Clinic Proceedings. Elsevier, 10:1326\u20131338"},{"key":"9686_CR8","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1073\/pnas.0400569101","volume":"101","author":"EJ Benner","year":"2004","unstructured":"Benner EJ et al. (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 101:9435\u20139440","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9686_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the neurological sciences 20:415\u2013455","journal-title":"Journal of the neurological sciences"},{"key":"9686_CR10","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/mt.2010.107","volume":"18","author":"K Biju","year":"2010","unstructured":"Biju K et al. (2010) Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol Ther: the J American Soc Gen Ther 18:1536\u20131544. doi: 10.1038\/mt.2010.107","journal-title":"Mol Ther: the J American Soc Gen Ther"},{"key":"9686_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","volume":"4","author":"A Bjorklund","year":"1997","unstructured":"Bjorklund A, Rosenblad C, Winkler C, Kirik D (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 4:186\u2013200. doi: 10.1006\/nbdi.1997.0151","journal-title":"Neurobiol Dis"},{"key":"9686_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1471-4159.2001.00294.x","volume":"77","author":"D Bozyczko-Coyne","year":"2001","unstructured":"Bozyczko-Coyne D, O'Kane TM, Wu ZL, Dobrzanski P, Murthy S, Vaught JL, Scott RW (2001) CEP-1347\/KT-7515, an inhibitor of SAPK\/JNK pathway activation, promotes survival and blocks multiple events associated with A\u03b2-induced cortical neuron apoptosis. J Neurochem 77:849\u2013863","journal-title":"J Neurochem"},{"key":"9686_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2217\/nnm.10.7","volume":"5","author":"AM Brynskikh","year":"2010","unstructured":"Brynskikh AM et al. (2010) Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomed: Nanotech biol Med 5:379\u2013396","journal-title":"Nanomed: Nanotech biol Med"},{"key":"9686_CR14","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder SP et al. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881\u20131893","journal-title":"Lancet"},{"key":"9686_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/15548627.2015.1121360","volume":"12","author":"Y Cai","year":"2016","unstructured":"Cai Y, Arikkath J, Yang L, Guo ML, Periyasamy P, Buch S (2016) Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy 12:225\u2013244. doi: 10.1080\/15548627.2015.1121360","journal-title":"Autophagy"},{"key":"9686_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2009.10.006","volume":"37","author":"B Cameron","year":"2010","unstructured":"Cameron B, Landreth GE (2010) Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 37:503\u2013509","journal-title":"Neurobiol Dis"},{"key":"9686_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-8-48","volume":"8","author":"S Cao","year":"2011","unstructured":"Cao S, Wu C, Yang Y, Sniderhan LF, Maggirwar SB, Dewhurst S, Lu Y (2011) Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS. J Neuroinflammation 8:48","journal-title":"J Neuroinflammation"},{"key":"9686_CR18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","volume":"20","author":"CK Combs","year":"2000","unstructured":"Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE (2000) Inflammatory mechanisms in Alzheimer's disease: inhibition of \u03b2-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR\u03b3 agonists. J Neurosci 20:558\u2013567","journal-title":"J Neurosci"},{"key":"9686_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","volume":"59","author":"A Czlonkowska","year":"1999","unstructured":"Czlonkowska A, Czlonkowski A, Kohutnicka M, Kurkowska-Jastrzebska I, Wronska a (1999) MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol Exp 59:1\u20138","journal-title":"Acta Neurobiol Exp"},{"key":"9686_CR20","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1523\/JNEUROSCI.5473-10.2011","volume":"31","author":"PK Dash","year":"2011","unstructured":"Dash PK et al. (2011) Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci 31:3148\u20133157","journal-title":"J Neurosci"},{"key":"9686_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1017\/S1355617711001408","volume":"18","author":"KN Devlin","year":"2011","unstructured":"Devlin KN et al. (2011) Neurocognitive effects of HIV, hepatitis C, and substance use history. J Int Neuropsychol Soc 18:68","journal-title":"J Int Neuropsychol Soc"},{"key":"9686_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND et al. (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214:193\u2013200. doi: 10.1016\/j.bbr.2010.05.023","journal-title":"Behav Brain Res"},{"key":"9686_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS et al. (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med 370:311\u2013321","journal-title":"N Engl J Med"},{"key":"9686_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4049\/jimmunol.0900274","volume":"183","author":"H Dou","year":"2009","unstructured":"Dou H et al. (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol (Baltimore, Md: 1950) 183:661\u2013669. doi: 10.4049\/jimmunol.0900274","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"9686_CR25","doi-asserted-by":"publisher","first-page":"dju090","DOI":"10.1093\/jnci\/dju090","volume":"106","author":"M Duebgen","year":"2014","unstructured":"Duebgen M, Martinez-Quintanilla J, Tamura K, Hingtgen S, Redjal N, Wakimoto H, Shah K (2014) Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. J Natl Cancer Inst 106:dju090. doi: 10.1093\/jnci\/dju090","journal-title":"J Natl Cancer Inst"},{"key":"9686_CR26","doi-asserted-by":"publisher","first-page":"A32","DOI":"10.1038\/399a032","volume":"399","author":"SB Dunnett","year":"1999","unstructured":"Dunnett SB, Bjorklund a (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399:A32\u2013A39","journal-title":"Nature"},{"key":"9686_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4049\/jimmunol.0902962","volume":"184","author":"D Eggert","year":"2010","unstructured":"Eggert D et al. (2010) Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol (Baltimore, Md: 1950) 184:746\u2013756. doi: 10.4049\/jimmunol.0902962","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"9686_CR28","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/nprot.2012.131","volume":"7","author":"S El-Andaloussi","year":"2012","unstructured":"El-Andaloussi S et al. (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112\u20132126. doi: 10.1038\/nprot.2012.131","journal-title":"Nat Protoc"},{"key":"9686_CR29","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.4049\/jimmunol.173.4.2762","volume":"173","author":"J Falsig","year":"2004","unstructured":"Falsig J, P\u00f6rzgen P, Lotharius J, Leist M (2004) Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J Immunol 173:2762\u20132770","journal-title":"J Immunol"},{"key":"9686_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","volume":"37","author":"R Gabathuler","year":"2010","unstructured":"Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases. Neurobiol Dis 37:48\u201357","journal-title":"Neurobiol Dis"},{"key":"9686_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.02.052","author":"P Garcia-Huerta","year":"2016","unstructured":"Garcia-Huerta P, Troncoso-Escudero P, Jerez C, Hetz C, Vidal RL (2016) The intersection between growth factors, autophagy and ER stress: a new target to treat neurodegenerative diseases? Brain Res. doi: 10.1016\/j.brainres.2016.02.052","journal-title":"Brain Res"},{"key":"9686_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/380252a0","volume":"380","author":"DM Gash","year":"1996","unstructured":"Gash DM et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252\u2013255. doi: 10.1038\/380252a0","journal-title":"Nature"},{"key":"9686_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.1365-2990.1999.00167.x","volume":"25","author":"F Gray","year":"1999","unstructured":"Gray F (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25:123\u2013133","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9686_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-015-0309-0","author":"J Hall","year":"2016","unstructured":"Hall J, Prabhakar S, Balaj L, Lai CP, Cerione RA, Breakefield XO (2016) Delivery of therapeutic proteins via extracellular vesicles: review and potential treatments for Parkinson's disease. Glioma, and Schwannoma Cell Mol Neurol. doi: 10.1007\/s10571-015-0309-0","journal-title":"Glioma, and Schwannoma Cell Mol Neurol"},{"key":"9686_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/intimm\/dxm050","volume":"19","author":"ME Handley","year":"2007","unstructured":"Handley ME, Rasaiyaah J, Barnett J, Thakker M, Pollara G, Katz DR, Chain BM (2007) Expression and function of mixed lineage kinases in dendritic cells. Int Immunol 19:923\u2013933","journal-title":"Int Immunol"},{"key":"9686_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","volume":"25","author":"J Harezlak","year":"2011","unstructured":"Harezlak J et al. (2011) Persistence of hiv\u2212 associated cognitive impairment, inflammation and neuronal injury in era of highly active antiretroviral treatment. AIDS (London, England) 25:625","journal-title":"AIDS (London, England)"},{"issue":"6617","key":"9686_CR37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/385645a0","volume":"385","author":"J He","year":"1997","unstructured":"He J et al. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385(6617):645\u2013649","journal-title":"Nature"},{"key":"9686_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM198702123160703","volume":"316","author":"T Hemachudha","year":"1987","unstructured":"Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P (1987) Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 316:369\u2013374. doi: 10.1056\/nejm198702123160703","journal-title":"N Engl J Med"},{"key":"9686_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463\u2013477","journal-title":"Nat Rev Immunol"},{"key":"9686_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0006-2952(02)01139-5","volume":"64","author":"U Hidding","year":"2002","unstructured":"Hidding U et al. (2002) The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. Biochem Pharmacol 64:781\u2013788","journal-title":"Biochem Pharmacol"},{"key":"9686_CR41","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/01.wnl.0000277648.63931.c0","volume":"69","author":"PSGP Investigators","year":"2007","unstructured":"Investigators PSGP (2007) Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 69:1480\u20131490","journal-title":"Neurology"},{"key":"9686_CR42","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/jm970031d","volume":"40","author":"M Kaneko","year":"1997","unstructured":"Kaneko M et al. (1997) Neurotrophic 3, 9-bis [(alkylthio) methyl]-and-bis (alkoxymethyl)-K-252a derivatives. J Med Chem 40:1863\u20131869","journal-title":"J Med Chem"},{"key":"9686_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347","journal-title":"Exp Mol Med"},{"key":"9686_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.3016903","volume":"233","author":"S Koenig","year":"1986","unstructured":"Koenig S et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089\u20131093","journal-title":"Science"},{"key":"9686_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1126\/science.290.5492.767","volume":"290","author":"JH Kordower","year":"2000","unstructured":"Kordower JH et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767\u2013773","journal-title":"Science"},{"key":"9686_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/13550280701327038","volume":"13","author":"AM Kumar","year":"2007","unstructured":"Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M (2007) Human immunodeficiency virus type 1 RNA levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. J Neurovirol 13:210\u2013224. doi: 10.1080\/13550280701327038","journal-title":"J Neurovirol"},{"key":"9686_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/nan.12250","volume":"41","author":"T Lashley","year":"2015","unstructured":"Lashley T, Rohrer JD, Mead S, Revesz T (2015) Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol 41:858\u2013881","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9686_CR48","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","volume":"25","author":"J Lotharius","year":"2005","unstructured":"Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, Leist M (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25:6329\u20136342","journal-title":"J Neurosci"},{"key":"9686_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.nano.2014.12.013","volume":"11","author":"SK Mallapragada","year":"2015","unstructured":"Mallapragada SK et al. (2015) Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomed: Nanotech Biol Med 11:715\u2013729. doi: 10.1016\/j.nano.2014.12.013","journal-title":"Nanomed: Nanotech Biol Med"},{"key":"9686_CR50","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.1523\/JNEUROSCI.0598-13.2013","volume":"33","author":"DF Marker","year":"2013","unstructured":"Marker DF et al. (2013) The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders. J Neurosci 33:9998\u201310010","journal-title":"J Neurosci"},{"key":"9686_CR51","doi-asserted-by":"publisher","first-page":"25302","DOI":"10.1074\/jbc.M011601200","volume":"276","author":"AC Maroney","year":"2001","unstructured":"Maroney AC et al. (2001) Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem 276:25302\u201325308","journal-title":"J Biol Chem"},{"key":"9686_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1615\/CritRevNeurobiol.v10.i1.30","volume":"10","author":"E Masliah","year":"1996","unstructured":"Masliah E, Ge N, Mucke L (1996) Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 10:57\u201367","journal-title":"Crit Rev Neurobiol"},{"key":"9686_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E et al. (2005) Effects of \u03b1-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868","journal-title":"Neuron"},{"key":"9686_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2003.11.073","volume":"1003","author":"JR Mathiasen","year":"2004","unstructured":"Mathiasen JR et al. (2004) Inhibition of mixed lineage kinase 3 attenuates MPP\u00a0+\u00a0\u2212induced neurotoxicity in SH-SY5Y cells. Brain Res 1003:86\u201397","journal-title":"Brain Res"},{"key":"9686_CR55","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL McGeer","year":"2004","unstructured":"McGeer PL, EG MG (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10:S3\u2013S7","journal-title":"Parkinsonism Relat Disord"},{"key":"9686_CR56","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574\u2013576. doi: 10.1002\/ana.410240415","journal-title":"Ann Neurol"},{"key":"9686_CR57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pbiomolbio.2006.07.019","volume":"93","author":"S Meairs","year":"2007","unstructured":"Meairs S, Alonso A (2007) Ultrasound, microbubbles and the blood\u2013brain barrier. Prog Biophys Mol Biol 93:354\u2013362","journal-title":"Prog Biophys Mol Biol"},{"key":"9686_CR58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","volume":"130","author":"LW Moreland","year":"1999","unstructured":"Moreland LW et al. (1999) Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 130:478\u2013486","journal-title":"Ann Intern Med"},{"key":"9686_CR59","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D et al. (2000) A\u03b2 peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982\u2013985","journal-title":"Nature"},{"key":"9686_CR60","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/mtna.2013.60","volume":"2","author":"JL Munoz","year":"2013","unstructured":"Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P (2013) Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids 2:e126. doi: 10.1038\/mtna.2013.60","journal-title":"Mol Ther Nucleic Acids"},{"key":"9686_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2217\/nnm.09.38","volume":"4","author":"A Nowacek","year":"2009","unstructured":"Nowacek A, Gendelman HE (2009) NanoART, neuroAIDS and CNS drug delivery. Nanomed: Nanotech Biol Med 4:557\u2013574","journal-title":"Nanomed: Nanotech Biol Med"},{"key":"9686_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/nnm.09.37","volume":"4","author":"A Nowacek","year":"2009","unstructured":"Nowacek A, Kosloski LM, Gendelman HE (2009) Neurodegenerative disorders and nanoformulated drug development. Nanomed (London, England) 4:541\u2013555. doi: 10.2217\/nnm.09.37","journal-title":"Nanomed (London, England)"},{"key":"9686_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0887-8994(00)00167-3","volume":"23","author":"H Ozawa","year":"2000","unstructured":"Ozawa H, Noma S, Yoshida Y, Sekine H, Hashimoto T (2000) Acute disseminated encephalomyelitis associated with poliomyelitis vaccine. Pediatr Neurol 23:177\u2013179","journal-title":"Pediatr Neurol"},{"key":"9686_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3\u201314","journal-title":"NeuroRx"},{"key":"9686_CR65","doi-asserted-by":"publisher","unstructured":"Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, Lopez-Barneo J (2008) Absolute requirement of GDNF for adult catecholaminergic neuron survival Nat Neurosci 11:755\u2013761 doi: 10.1038\/nn.2136","DOI":"10.1038\/nn.2136"},{"key":"9686_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/187221109787158355","volume":"3","author":"SA Pathan","year":"2009","unstructured":"Pathan SA et al. (2009) CNS drug delivery systems: novel approaches. Recent Pat Drug Deliv Formul 3:71\u201389","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"9686_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193\u2013201","journal-title":"Nat Rev Neurol"},{"key":"9686_CR68","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1189\/jlb.0503205","volume":"74","author":"Y Persidsky","year":"2003","unstructured":"Persidsky Y, Gendelman HE (2003) Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74:691\u2013701","journal-title":"J Leukoc Biol"},{"key":"9686_CR69","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al. (1997) ) Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"9686_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrn2398","volume":"9","author":"PG Popovich","year":"2008","unstructured":"Popovich PG, Longbrake EE (2008) Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9:481\u2013493. doi: 10.1038\/nrn2398","journal-title":"Nat Rev Neurosci"},{"key":"9686_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0079-6123(09)17514-3","volume":"175","author":"S Ramaswamy","year":"2009","unstructured":"Ramaswamy S, Soderstrom KE, Kordower JH (2009) Trophic factors therapy in Parkinson's disease. Prog Brain Res 175:201\u2013216. doi: 10.1016\/s0079-6123(09)17514-3","journal-title":"Prog Brain Res"},{"key":"9686_CR72","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122:1164\u20131171","journal-title":"J Clin Invest"},{"key":"9686_CR73","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2565","volume":"9","author":"S Rivest","year":"2009","unstructured":"Rivest S (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9:429\u2013439. doi: 10.1038\/nri2565","journal-title":"Nat Rev Immunol"},{"key":"9686_CR74","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2009) Inflammation in Alzheimer's disease: amyloid-\u03b2 oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 87:181\u2013194","journal-title":"Prog Neurobiol"},{"key":"9686_CR75","first-page":"421","volume":"288","author":"MS Saporito","year":"1999","unstructured":"Saporito MS, Brown EM, Miller MS, Carswell S (1999) CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J Pharmacol Exp Ther 288:421\u2013427","journal-title":"J Pharmacol Exp Ther"},{"key":"9686_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0079-6468(08)70081-X","volume":"40","author":"MS Saporito","year":"2002","unstructured":"Saporito MS, Hudkins RL, Maroney AC (2002) 2 discovery of Cep-1347\/Kt-7515, an inhibitor of the Jnk\/Sapk pathway for the treatment of neurodegenerative diseases. Prog Med Chem 40:23\u201362","journal-title":"Prog Med Chem"},{"key":"9686_CR77","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","volume":"21","author":"G Schifitto","year":"2007","unstructured":"Schifitto G et al. (2007) Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21:1877\u20131886","journal-title":"AIDS"},{"key":"9686_CR78","doi-asserted-by":"publisher","unstructured":"Schneeberger A, Tierney L, Mandler M (2015) Active immunization therapies for Parkinson's disease and multiple system atrophy Mov Disord 10.1002\/mds.26377","DOI":"10.1002\/mds.26377"},{"key":"9686_CR79","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.2174\/0929867311320200006","volume":"20","author":"S Shi","year":"2013","unstructured":"Shi S, Wang Z, Qiao Z (2013) The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease. Curr Med Chem 20:2583\u20132588","journal-title":"Curr Med Chem"},{"key":"9686_CR80","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1523\/JNEUROSCI.0936-06.2006","volume":"26","author":"AY Shih","year":"2006","unstructured":"Shih AY et al. (2006) Policing the police: astrocytes modulate microglial activation. J Neurosci 26:3887\u20133888. doi: 10.1523\/jneurosci.0936-06.2006","journal-title":"J Neurosci"},{"key":"9686_CR81","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/imm.12170","volume":"141","author":"SD Skaper","year":"2014","unstructured":"Skaper SD, Facci L, Giusti P (2014) Mast cells, glia and neuroinflammation: partners in crime? Immunology 141:314\u2013327. doi: 10.1111\/imm.12170","journal-title":"Immunology"},{"key":"9686_CR82","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.4049\/jimmunol.181.12.8604","volume":"181","author":"LN S\u00f8rensen","year":"2008","unstructured":"S\u00f8rensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR (2008) TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain the. J Immunol 181:8604\u20138612","journal-title":"J Immunol"},{"key":"9686_CR83","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"9686_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/glia.440010502","volume":"1","author":"WJ Streit","year":"1988","unstructured":"Streit WJ, Graeber MB, Kreutzberg GW (1988) Functional plasticity of microglia: a review. Glia 1:301\u2013307","journal-title":"Glia"},{"key":"9686_CR85","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4049\/jimmunol.177.1.702","volume":"177","author":"Z Sui","year":"2006","unstructured":"Sui Z et al. (2006) Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation. J Immunol 177:702\u2013711","journal-title":"J Immunol"},{"key":"9686_CR86","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","volume":"179","author":"KA Thompson","year":"2011","unstructured":"Thompson KA, Cherry CL, Bell JE, McLean CA (2011) Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol 179:1623\u20131629","journal-title":"Am J Pathol"},{"key":"9686_CR87","first-page":"25","volume":"8","author":"E Tobinick","year":"2006","unstructured":"Tobinick E, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. Med Gen Med: Medscape Gen Med 8:25","journal-title":"Med Gen Med: Medscape Gen Med"},{"key":"9686_CR88","doi-asserted-by":"crossref","unstructured":"Verderio C, Matteoli, M (2001) ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J Immunol (Baltimore, MD: 1950) 166:6383\u20136391","DOI":"10.4049\/jimmunol.166.10.6383"},{"key":"9686_CR89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199007263230406","volume":"323","author":"RJ Whitley","year":"1990","unstructured":"Whitley RJ (1990) Viral encephalitis. N Engl J Med 323:242\u2013250","journal-title":"N Engl J Med"},{"key":"9686_CR90","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1189\/jlb.0811394","volume":"91","author":"DW Williams","year":"2012","unstructured":"Williams DW, Eugenin EA, Calderon TM, Berman JW (2012) Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91:401\u2013415","journal-title":"J Leukoc Biol"},{"key":"9686_CR91","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","volume":"120","author":"EH Wilson","year":"2010","unstructured":"Wilson EH, Weninger W, Hunter CA (2010) Trafficking of immune cells in the central nervous system. J Clin Invest 120:1368\u20131379. doi: 10.1172\/jci41911","journal-title":"J Clin Invest"},{"key":"9686_CR92","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/mp300495e","volume":"10","author":"DJ Wolak","year":"2013","unstructured":"Wolak DJ, Thorne RG (2013) Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 10:1492\u20131504","journal-title":"Mol Pharm"},{"key":"9686_CR93","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/evj.12403","volume":"47","author":"E Woodward","year":"2015","unstructured":"Woodward E, Troedsson M (2015) Inflammatory mechanisms of endometritis. Equine Vet J 47:384\u2013389","journal-title":"Equine Vet J"},{"key":"9686_CR94","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3109\/01902140902853168","volume":"35","author":"SK Young","year":"2009","unstructured":"Young SK, Arndt PG (2009) c-Jun NH2-terminal kinase regulates lipopolysaccharide-induced pulmonary mononuclear cell recruitment via CCL2. Exp Lung Res 35:682\u2013700","journal-title":"Exp Lung Res"},{"key":"9686_CR95","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755\u20131761. doi: 10.1182\/blood-2005-04-1496","journal-title":"Blood"},{"key":"9686_CR96","first-page":"109","volume":"12","author":"G Zhang","year":"2016","unstructured":"Zhang G et al. (2016) The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy nanomedicine: nanotechnology. Biomark Med 12:109\u2013122","journal-title":"Biomark Med"},{"key":"9686_CR97","first-page":"pii","volume":"S4","author":"Y Zhao","year":"2011","unstructured":"Zhao Y et al. (2011) Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson\u2019s disease. J Nanosci Nanotechnol S4:pii\u2013003","journal-title":"J Nanosci Nanotechnol"},{"key":"9686_CR98","doi-asserted-by":"publisher","first-page":"e106867","DOI":"10.1371\/journal.pone.0106867","volume":"9","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Haney MJ, Gupta R, Bohnsack JP, He Z, Kabanov AV, Batrakova EV (2014) GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model. PLoS One 9:e106867. doi: 10.1371\/journal.pone.0106867","journal-title":"PLoS One"},{"key":"9686_CR99","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2008.06.015","volume":"200","author":"JC Zheng","year":"2008","unstructured":"Zheng JC et al. (2008) HIV-1-infected and\/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1\u03b2 and TNF-\u03b1: Involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol 200:100\u2013110","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9686-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-016-9686-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9686-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9686-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:44:55Z","timestamp":1718667895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-016-9686-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s11481-016-9686-5","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"type":"print","value":"1557-1890"},{"type":"electronic","value":"1557-1904"}],"subject":[],"published":{"date-parts":[[2016,6,28]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}